Table 2 Suicide-related events: categorization of results-from acute, paediatric, active comparator-controlled studies in ADHD (FDA-defined approach)
Code 1 | Code 2 | Code 3 | Code 4 | Code 5 | Code 9 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | ATX n/N | MPH n/N | ATX n/N | MPH n/N | ATX n/N | MPH n/N | ATX n/N | MPH n/N | ATX n/N | MPH n/N | ATX n/N | MPH n/N |
HFBD | 0/65 | 0/20 | 0/65 | 0/20 | 0/65 | 0/20 | 1/65 | 0/20 | 0/65 | 0/20 | 0/65 | 0/20 |
HFBK | 0/64 | 0/18 | 0/64 | 0/18 | 0/64 | 0/18 | 0/64 | 0/18 | 1/64 | 0/18 | 1/64 | 0/18 |
LYAV | 0/44 | 0/41 | 0/44 | 0/41 | 0/44 | 0/41 | 0/44 | 1/41 | 0/44 | 0/41 | 0/44 | 0/41 |
LYBI | 0/222 | 0/220 | 0/222 | 0/220 | 0/222 | 0/220 | 0/222 | 0/220 | 0/222 | 0/220 | 0/222 | 0/220 |
LYBR | 0/164 | 0/166 | 0/164 | 0/166 | 0/164 | 0/166 | 0/164 | 0/166 | 0/164 | 0/166 | 0/164 | 1/166 |
TOTAL | 0/559 | 0/465 | 0/559 | 0/465 | 0/559 | 0/465 | 1/559 | 1/465 | 1/559 | 0/465 | 1/559 | 1/465 |